DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Picotamide
Picotamide
Prevention of Atherothrombotic Events in Patients with Diabetes Mellitus: from Antithrombotic Therapies to New-Generation Glucose-Lowering Drugs
Comparative Efficacy and Safety of Different Antiplatelet Agents For
Study Protocol
Acute Reduction of Txa2 Platelet Binding Sites After in Vivo
Treatment Strategies for Patients with Peripheral Artery Disease
Synthesis, in Vitro Cytotoxicity and Anti-Platelet Activity of New 1,3-Bentzenedisulfonamides
(12) United States Patent (10) Patent No.: US 8,026,285 B2 Bezwada (45) Date of Patent: Sep
(12) United States Patent (10) Patent No.: US 8,835,407 B2 Mosher Et Al
Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current
Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes
Variabilidad Farmacodinámica En La Respuesta a Clopidogrel: Mecanismos Implicados Y Uso De Inhibidores Más Potentes Del Recept
Head Injury Partial Update
Reproductive Health Guideline Appendix 3 – Search Strategies
Search Strategy Systematic Review of Effect of Statins and Antiplatelets On
Project SCYLLA
Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
Antiplatelet Agents for Chronic Kidney Disease (Review)
2020.05.19.103945V1.Full.Pdf
Top View
AAN/AHS Update Recommendations for Migraine Prevention in Adults
Interactions and Incompatibilities of Pharmaceutical Excipients with Active Pharmaceutical Ingredients: a Comprehensive Review
Peripheral-Artery-Disease-Treatment
Pharmaceutical Compositions Comprising Prasugrel And
052401 Medical Treatment of Peripheral Arterial Disease
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Recent Progress and Market Analysis of Anticoagulant Drugs
List of Texts Adopted at the November 2015 Session of the European Pharmacopoeia Commission
Antiplatelet Therapies for the Treatment of Cardiovascular Disease
Aspirin Blocks Formation of Metastatic Intravascular Niches by Inhibiting Platelet-Derived COX-1/Thromboxane A2
Tissue‐Resident Macrophages Actively
(12) United States Patent (10) Patent No.: US 7,235,567 B2 W (45) Date of Patent: *Jun
Tissue‐Resident Macrophages Actively Suppress IL
Migraine Diagnosis and Treatment Vitaliy Koss MD Lehigh Valley Health Network,
[email protected]
Antithromboticc Drugs in the Primary Medicall Management of Intermittent Claudication N
WO 2U11/132171 Al
Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia
Known Bioactives Library: Prestwick 2 Collection
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Antiplatelet Therapy – a Pharmacologist’S Perspective
JBAK Protocol (E) Phase 2 Study of LY2157299 in Patients With
Picotamide Reduced All Cause Mortality More Than Aspirin in Type 2 Diabetes Mellitus and Peripheral Arterial Disease Neri Serneri GG, Coccheri S, Marubini E, Et Al
Role of and Recent Evidence for Antiplatelet Therapy in Prevention of Cardiovascular Disease in Diabetes
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Thromboxane Receptors Antagonists And/Or Synthase Inhibitors
Drugs and Devices for Migraine Prevention: Interactive Evidence Maps
Low-Dose Thromboxane A2 Receptor Stimulation Promotes Closure of The